NCT04208230View on ClinicalTrials.gov

Progression and Etiology of Cortical Porosity in Diabetic Bone Disease

CompletedOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

January 3, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

November 15, 2023

Conditions
Type 2 Diabetes
Interventions
DEVICE

XtremeCT

HRpQCT technology provides information on bone microarchitecture, bone density and bone strength by measuring the cortical and trabecular bone structures with improved spatial resolution and defining the surfaces in three-dimensional manner.

Trial Locations (1)

94197

University of California San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT04208230 - Progression and Etiology of Cortical Porosity in Diabetic Bone Disease | Biotech Hunter | Biotech Hunter